Assessing Patient Outcomes: A Meta-Analysis of Pro Yellow Laser Therapy for Rosacea Symptom Relief

Rosacea is a chronic inflammatory vascular skin disorder characterized, inter alia, by persistent facial erythema, telangiectasia, and inflammatory papules that deplorably affect the quality of life in people found in such circumstances. Considered in such categories under laser treatment, it is the 577-nm pro-yellow laser with claims to fame as an absorber of hemoglobin, allowing selective photothermolysis of abnormal vessels with great efficacy and safety. This meta-analysis systematically reviews 11 clinical studies that evaluate the therapeutic outcomes conferred upon rosacea and related vascular dermatoses by pro-yellow laser treatment. Thus, our paper consists of 11 clinical studies consisting of prospective trials, retrospective case analyses, and randomized comparisons on patient populations diagnosed with erythemotelangiectatic rosacea, post-acne erythema, and other vascular skin lesions. Furthermore, says protocols involved from single-session applications to multiple monthly sessions, with laser parameters usually close to 20 J/cm². Outcome measurement in various studies incorporated assessment of clinical erythema and telangiectasia clearance by dermatological evaluation and photographic imaging, patient-reported symptoms.